The9 Ltd
NCTY
Bit Digital
BTBT
TeraWulf
WULF
Digihost Technology
DGHI
BTCS Inc
BTCS
US Stock MarketDetailed Quotes
ALT Altimmune
- 5.570
- -0.020-0.36%
Close Mar 27 16:00 ET
- 5.600
- +0.030+0.53%
Post 20:01 ET
428.97MMarket Cap-4.16P/E (TTM)
5.630High5.450Low1.62MVolume5.575Open5.590Pre Close8.99MTurnover2.13%Turnover RatioLossP/E (Static)77.01MShares11.16052wk High3.47P/B425.19MFloat Cap5.14052wk Low--Dividend TTM76.34MShs Float978.000Historical High--Div YieldTTM3.22%Amplitude-1731.000Historical Low5.533Avg Price1Lot Size
Market Insights
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks
Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.
Altimmune Stock Forum
$Altimmune (ALT.US)$
$Altimmune (ALT.US)$
Altimmune Presents New Data on the Effect of Pemvidutide on Inflammatory Lipids in Subjects with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) at The Liver Meeting® 2024
Altimmune (Nasdaq: ALT) presented new data from its 12-week Phase 1b trial of pemvidutide in MASLD patients at The Liver Meeting®.
The study demonstrated that weekly subcutaneous doses of pemvidutide significantly reduced inflammatory lipids and showed promising effects on cardiovascul...
Larger Image: tradingview.com...
$Altimmune (ALT.US)$
No comment yet